Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 6:37 pm Unchanged | 2026-03-13 | 13G | Fulcrum Therapeutics, Inc. FULC | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:29 pm Purchase | 2025-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 6,649,973 9.900% | 596,013 (+9.85%) | Filing History |
| 2025-12-10 4:44 pm Purchase | 2025-12-08 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 6,053,960 11.200% | 6,053,960 (New Position) | Filing History |
| 2025-11-13 09:03 am Sale | 2025-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | Adage Capital Management, L.P. | 2,432,000 4.500% | -2,157,000 (-47.00%) | Filing History |
| 2025-10-17 6:40 pm Sale | 2025-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | BLACKROCK INC BLK | 3,270,322 6.000% | -762,554 (-18.91%) | Filing History |
| 2025-08-12 09:01 am Purchase | 2025-06-30 | 13G | Fulcrum Therapeutics, Inc. FULC | Adage Capital Management, L.P. | 4,589,000 8.500% | 1,589,000 (+52.97%) | Filing History |
| 2025-05-02 5:33 pm Purchase | 2025-03-31 | 13G | Fulcrum Therapeutics, Inc. FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 5,067,394 9.400% | 1,662,782 (+48.84%) | Filing History |
| 2025-04-17 09:35 am Purchase | 2025-03-31 | 13G | Fulcrum Therapeutics, Inc. FULC | BLACKROCK INC BLK | 4,032,876 7.500% | 4,032,876 (New Position) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Adage Capital Management, L.P. | 3,000,000 5.560% | 3,000,000 (New Position) | Filing History |
| 2025-01-06 4:50 pm Purchase | 2024-12-27 | 13G | Fulcrum Therapeutics, Inc. FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 3,404,612 6.300% | 3,404,612 (New Position) | Filing History |
| 2024-12-06 4:28 pm Unchanged | 2024-12-06 | 13G | Fulcrum Therapeutics, Inc. FULC | BLACKROCK INC BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | Nantahala Capital Management LLC | 4,777,912 7.657% | 4,777,912 (New Position) | Filing History |
| 2024-11-14 4:25 pm Unchanged | 2024-11-14 | 13G | Fulcrum Therapeutics, Inc. FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 06:15 am Unchanged | 2024-11-14 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-12 3:51 pm Unchanged | 2024-11-12 | 13G | Fulcrum Therapeutics, Inc. FULC | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-11-08 | 13G | Fulcrum Therapeutics, Inc. FULC | BLACKROCK INC BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-04 11:49 am Unchanged | 2024-11-04 | 13G | Fulcrum Therapeutics, Inc. FULC | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-10-21 4:11 pm Unchanged | 2024-10-21 | 13G | Fulcrum Therapeutics, Inc. FULC | BLACKROCK INC BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-10-07 11:37 am Unchanged | 2024-10-07 | 13G | Fulcrum Therapeutics, Inc. FULC | FMR CORP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-09-20 4:21 pm Unchanged | 2024-09-20 | 13G | Fulcrum Therapeutics, Inc. FULC | TCG Crossover GP II LLC | 0 0.000% | 0 (Unchanged) | Filing |